[ET Net News Agency, 21 March 2023] JD HEALTH (06618) rose 5.04% to HK$59.35, breaking
above the 250-D SMA of HK$56.814.
It hits an intra-day high of HK$59.4, and an intra-day low of HK$56.15. The total shares
traded was 4.14 million, with a value of HK$240.4m. The active buy/sell ratio is 59:41,
with net buying turnover of HK$40.71m. INSTINET PACIFIC accounts for greatest net
responsive buying turnover of HK$7.93m, with volume weighted average price of HK$57.914.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$17.24m,
with volume weighted average price of HK$58.145.
The Hang Seng China Enterprises Index now rose 90 points, or 1.4% to 6,560; the Hang
Seng TECH Index now rose 104 points, or 2.7% to 3,974.
Basic Information
=================
---------------------------------
Nominal 59.350 % Chg +5.04%
High 59.400 Low 56.150
Shares Tr 4.14m Turnover 240.4m
10-D SMA 56.395 %H.V 61.881
20-D SMA 57.382 VWAP 58.013
50-D SMA 61.582 RSI14 51.718
---------------------------------
Status: Breaking above the 250-D SMA, active buy/sell ratio is 59:41, with net buying
turnover of HK$40.71m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
JD HEALTH (06618) 59.35 +5.04
ALI HEALTH (00241) 5.98 +2.93
SINOPHARM (01099) 23.15 +0.65
SINO BIOPHARM (01177) 4.40 +3.29
INNOVENT BIO (01801) 40.95 +8.05
JXR (01951) 5.36 +3.47
WUXI BIO (02269) 49.40 +9.41
HYGEIA HEALTH (06078) 58.65 +4.64
ZAI LAB (09688) 25.40 -1.17
AKESO-B (09926) 44.25 +2.79
---------------------------------------------
(ed)